This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Queen's University directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Are Next-Generation Pathogenicity Predictors Applicable to Cancer?
Journal of molecular biology · 2024 · senior author
Latest funding
- $25,000
Deciphering the functional significance and physico-chemical mechanisms of histone post-translational modification cross-talk
NSERC · 2022 · Principal investigator
- $108,000
Deciphering the Mechanisms of Modulation of DNA Accessibility in Chromatin: Discovery of Novel Pioneer Transcription Factors
NSERC · 2021 · Principal investigator
- $250,000
Unraveling the landscape of oncohistone mutations
SSHRC · 2021 · Principal investigator
1 publications.
Are Next-Generation Pathogenicity Predictors Applicable to Cancer?
Ostroverkhova D, Sheng Y, Panchenko A
Deciphering the functional significance and physico-chemical mechanisms of histone post-translational modification cross-talk
Principal investigators: Panchenko, Anna AR
Deciphering the Mechanisms of Modulation of DNA Accessibility in Chromatin: Discovery of Novel Pioneer Transcription Factors
Principal investigators: Panchenko, Anna
Unraveling the landscape of oncohistone mutations
Principal investigators: Panchenko, Anna
Keywords: histones epigenetics cancer mutations nucleosome molecular modeling molecular dynamics simulations mass spectrometry machine learning protein-protein interactions post-translational modifications
Canada Research Chair - Tier 1
Principal investigators: Panchenko, Anna
Keywords: Crc
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.